Dishant Gupta was director of strategy and operations in the Cambridge office of Ipsen where he learned from co-workers that Ipsen was intent on buying Epizyme in early 2022.

Founded in 1989, Vaishali Pharma is one of the fastest-growing firms in the pharmaceutical sector. It announced a 1:1 bonus ...

India's commitment to biotechnology growth highlighted by Minister of State for Science and Technology, emphasizing ...

With Pfizer’s revenue and share price slumping after the drugmaker skyrocketed to new heights during the pandemic, the ...

The farmers clashed with police near Hakimpet, while they were on their way to the Dudyal Mandal Revenue Officer's office in ...

Large pharmaceutical companies were out in force at this week’s 2024 Cell & Gene Meeting on the Mesa, as they look to expand ...

Some six years after picking up Seattle’s Universal Cells for $102 million, Astellas Pharma is opening a second location for ...

Stay informed with the Sun Pharma Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...

Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the sustainability ...

Roche Holding AG will add manufacturing capacity in China to serve the country’s growing market, making it the latest ...

Managers face a variety of challenges during their careers. Instead of falling into fight or flight, develop resilience to ...